In patients with elevated serum CA 19-9 (≥35 kU/L), the median was numerically higher in those with with BRAF-mutant tumours (853 kU/L) compared to those with RAS-mutant or RAS/BRAF wild-type tumours (336 and 254 kU/L, respectively). Here, BRAF is linked to neoplasm.